Menicon acquires all shares of Tomey from Tomey Shoji

NewsGuard 100/100 Score

Menicon Co., Ltd. announced on March 17 that it had acquired all shares of Tomey Co., Ltd. from Tomey Shoji Inc. The deal was completed on February 1, 2010.

Tomey Co. is a major Japan-based manufacturer of contact lens care solutions, soft contact lenses, and RGP materials, and has been in operation since 1971. Tomey Co. has been the contracted supplier to Menicon Co., Ltd. of contact lens care solutions, and the exclusive supplier of Menicon monthly replacement soft contact lenses, and latheable RGP and soft lens materials including Menicon Z, Menicon EX, Menisoft and Menicon Soft 72. This acquisition enables Menicon to control completely the manufacture of its lens and lens care products, and will strengthen the company's competitiveness in Japan as well as in the global markets.

Tomey Co. will be renamed MeniconNect. A former director of Tomey Co., Hirofumi Minamikawa, was appointed to lead MeniconNect as its President, with Tokiyasu Tsuchida of Menicon named Executive Vice President of MeniconNect. Together, they will form a new management team to steer the company as one of the Menicon group companies. All former Tomey Co. employees will remain in MeniconNect and the manufacturing facilities will stay as they are.

"Menicon is very pleased to complete, through this acquisition, the vertical integration of manufacturing and material procurement into operation. Having complete control of manufacturing operations will help us provide even better products and services, and excellent value to all our customers in Japan and around the world. This will certainly help us accelerate our global business expansion," commented Dr. Hidenari Tanaka, President of Menicon Co.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Selkirk Pharma announces new APS qualified facility with advanced fill/finish capacity in Spokane, WA